Evidence map›Paper›PMID 24696669›Full record

ArticleTheScientificWorldJournal2014

Prospective study of BK virus infection in patients with inflammatory bowel disease.

Virginia Flores, Belén Rodríguez-Sánchez, Ignacio Marín-Jiménez, Emilio Bouza, Luis Menchén, Patricia Muñoz

Open access · goldAbstract read
In one paragraph

Article in TheScientificWorldJournal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review article: BK virus in systemic lupus erythematosus.Pediatric rheumatology online journal · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Virginia FloresDepartment of Digestive Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain ; CIBER Hepatic and Digestive Diseases (CIBEREHD), 07110 Bunyola, Balearic Islands, Spain.
Belén Rodríguez-SánchezDepartment of Clinical Microbiology and Infectious Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain ; CIBER Respiratory Diseases (CIBERES CB06/06/0058), 07110 Bunyola, Balearic Islands, Spain.
Ignacio Marín-JiménezDepartment of Digestive Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain ; CIBER Hepatic and Digestive Diseases (CIBEREHD), 07110 Bunyola, Balearic Islands, Spain.
Emilio BouzaDepartment of Clinical Microbiology and Infectious Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain ; CIBER Respiratory Diseases (CIBERES CB06/06/0058), 07110 Bunyola, Balearic Islands, Spain ; Department of Medicine, Faculty of Medicine, Complutense University of Madrid, 28040 Madrid, Spain ; Spanish Study Group on Infection in Transplant Recipients (GESITRA-RESITRA-REIPI), RD06/0008/1025, Spain.
Luis MenchénDepartment of Digestive Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain ; CIBER Hepatic and Digestive Diseases (CIBEREHD), 07110 Bunyola, Balearic Islands, Spain.
Patricia MuñozDepartment of Clinical Microbiology and Infectious Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain ; CIBER Respiratory Diseases (CIBERES CB06/06/0058), 07110 Bunyola, Balearic Islands, Spain ; Department of Medicine, Faculty of Medicine, Complutense University of Madrid, 28040 Madrid, Spain ; Spanish Study Group on Infection in Transplant Recipients (GESITRA-RESITRA-REIPI), RD06/0008/1025, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital General Universitario Gregorio Marañón · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with inflammatory bowel disease (IBD) have an immune-deficient baseline status further modulated by immunosuppressive therapy that may promote the reactivation of latent viruses such as BK virus (BKV). The aim of this prospective study was to determine the prevalence of BKV infection in IBD patients and its potential relationship with the immunosuppressive treatment. Paired urine and plasma samples from 53 consecutive patients with IBD and 53 controls were analyzed. BKV detection was performed by conventional PCR and positive samples were further quantified by real-time PCR. No viremia was detected. BKV viruria was significantly more common in IBD patients than among the controls (54.7% versus 11.3%; P < 0.0001). The only risk factor for BKV viruria in IBD was age (47.2 ± 16.3 versus 37.8 ± 15.2; P = 0.036), and there was a trend towards higher rate of viruria in outpatients (61.5% versus 38.5%; P = 0.096) and in those not receiving ciprofloxacin (59.5% versus 40.5%; P = 0.17). A clear impact of the immunosuppressive regimen on BKV infection could not be demonstrated.

Indexed as

AdolescentAdultAgedAge FactorsBK VirusCase-Control StudiesCiprofloxacinFemaleHumansImmunosuppressive AgentsInflammatory Bowel DiseasesMaleMiddle AgedPolyomavirus InfectionsProspective StudiesRisk FactorsCiprofloxacinImmunosuppressive Agents

Identifiers

PMID24696669
PMCPMC3947848
OpenAlexW2005531833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.